Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.33 |
| ▸ | PLAT | P00750 | 2/20 | 0.33 |
| ▸ | HTR2C | P28335 | 5/20 | 0.33 |
| ▸ | IKBKB | O14920 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.32 |
| ▸ | HTR1A | P08908 | 2/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8344150 | 0.90 | IKBKB (0.35) | GSK3BPLATHTR2CIKBKBSLC6A2 | |
| SCHEMBL6221027 | 0.90 | GSK3B (0.33) | GSK3BIKBKBHTR6 | |
| Hydrochloric Acid SCHEMBL6293704 | 0.89 | GSK3B (0.32) | GSK3BHTR2CIKBKBHTR6 | |
| SCHEMBL6221768 | 0.88 | HTR1A (0.37) | GSK3BHTR2CIKBKBKDM4EALDH1A1 | |
| SCHEMBL8344295 | 0.88 | HTR2C (0.45) | GSK3BHTR2CKDM4EALDH1A1MAPT | |
| SCHEMBL6296527 | 0.88 | GSK3B (0.36) | GSK3BHTR2CIKBKBKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL6296797 | 0.87 | HTR1A (0.36) | GSK3BHTR2CIKBKBKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL6220172 | 0.87 | EEF2K (0.40) | HTR2CMAPTSMN1; SMN2SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL6296665 | 0.87 | GSK3B (0.36) | GSK3BHTR2CIKBKBKDM4EALDH1A1 | |
| SCHEMBL6297315 | 0.87 | SLC18A3 (0.39) | HTR2CIKBKBKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6977262-B2 | Dihydropyrazolopyridine compounds and pharmaceutical use thereof | MITSUBISHI PHARMA CORPORATION (JP) | 2005-12-20 | — | — | US | disclosed |
| US-20040052822-A1 | Dihydropyrazolopyridine compounds and pharmaceutical use thereof | MITSUBISHI PHARMA CORPORATION (JP) | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040052822-A1 | Dihydropyrazolopyridine compounds and pharmaceutical use thereof | GSK3B, GSK3A, PYGB | GSK3B 1/4885PLAT 3038/4885HTR2C 2999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.